3191 results for «684»
3191 results
The use of adjunct devices in complex PCI
11 Oct 2025 – From AICT-AsiaPCR 2025
This session offers comprehensive education on the use of adjunct devices in complex PCI, focusing on different microcatheter designs and their optimal handling. It includes case-based illustrations demonstrating microcatheter applications, guidance on utilizing pre-shaped angled microcatheters in difficult anatomies, and the pivotal role of extension guide...
Complex coronary interventions - Current day challenges and solutions
11 Oct 2025 – From AICT-AsiaPCR 2025
Addressing current challenges in complex coronary interventions, this session covers management strategies for CHIP patients, advanced techniques for highly calcified lesions, and principles for mechanical circulatory support application in high-risk PCI scenarios. It offers practical insights and case-based discussions to optimize safety and efficacy in contemporary...
Very resistant stenosis in stent failure - LIVE Case
11 Oct 2025 – From AICT-AsiaPCR 2025
A 57-year-old male with a history of multivessel PCI—LAD and LCX stents in 2012 and RCA CTO stent in 2022—presented with normal LV function. He was asymptomatic but had a positive nuclear stress test. Control angiography showed suboptimal left coronary arteries with negative iFR. However, there...
Coronary complications and rescue cases
11 Oct 2025 – From AICT-AsiaPCR 2025
This compelling session addresses complex coronary complications and rescue cases encountered in the cath lab. Through a series of challenging case studies, it highlights critical scenarios such as silent coronary artery threats, procedural nightmares, coronary perforations, and innovative rescue strategies that transform high-risk situations into successful...
TAVI and aortic valve procedures
11 Oct 2025 – From AICT-AsiaPCR 2025
Focusing on transcatheter aortic valve interventions, this session covers a broad spectrum of complex cases including emergent TAV-in-SAV procedures, management of severely calcified bicuspid valves, zero-contrast TAVI techniques, and strategies for hostile anatomies. It provides valuable insights into procedural planning and follow-up to optimize patient care...
AICT-AsiaPCR 2025 Opening ceremony
10 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial
18 May 2021
Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)
01 Apr 2025
Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.
Author
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial
05 Mar 2023
Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.
Author
